In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Sadikovic, Bekim ^a,b   Yoshimoto, Maisa ^b   Al Romaih, Khaldoun ^b   Maire, Georges ^b   Zielenska, Maria ^a   Squire, Jeremy A ^b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION MOLECULE WITH IMMUNOGLOBULIN LIKE DOMAIN 2; CELL PROTEIN; EXOSTOSES 1 PROTEIN; MAB 21 LIKE 2 PROTEIN; ONCOPROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCND3; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE 32C; PROTOCADHERIN BETA 8; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LHX9; WILMS TUMOR 1 PROTEIN; DNA;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOBLAST; OSTEOSARCOMA; OSTEOSARCOMA CELL; ANIMAL; BIOLOGICAL MODEL; BONE TUMOR; CHEMISTRY; CONFORMATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENOME; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; MICE; MODELS, BIOLOGICAL; MODELS, GENETIC; NUCLEIC ACID CONFORMATION; OSTEOSARCOMA;

EID: 50949113230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002834     Document Type: Article

References (55)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
2. Rodenhiser D, Mann M (2006) Epigenetics and human disease: translating basic biology into clinical applications. Cmaj 174: 341-348.
3. Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298.
4. Momparler RL, Bovenzi V (2000) DNA methylation and cancer. J Cell Physiol 183: 145-154.
5. Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22: 4632-4642.
6. Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-5413.
7. Bedford MT, van Helden PD (1987) Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res 47: 5274-5276.
8. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, et al. (2001) Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res 61: 4238-4243.
9. Kim YI, Giuliano A, Hatch KD, Schneider A, Nour MA, et al. (1994) Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 74: 893-899.
10. Wahlfors J, Hiltunen H, Heinonen K, Hamalainen E, Alhonen L, et al. (1992) Genomic hypomethylation in human chronic lymphocytic leukemia. Blood 80: 2074-2080.
11. Feinberg AP, Vogelstein B (1983) Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 111: 47-54.
12. Nihigaki M, Aoyagi K, Danjoh I, Fukaya M, Yanagihara K, et al. (2005) Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res 65: 2115-2124.
13. Papaggeli PC, Kortsaris AC, Matsouka PT (2003) Aberrant methylation of cmyc and c-fcs protooncogenes and p53 tumor suppressor gene in myelodys-plastic syndromes and acute non-lymphocytic leukemia. J Buon 8: 341-350.
14. Alves G, Tatro A, Fanning T (1996) Differential methylation of human LINE-1 retrotransposons in malignant cells. Gene 176: 39-44.
15. Singer MF, Krek V, McMillan JP, Swergold GD, Thayer RE (1993) LINE-1: a human transposable element. Gene 135: 183-188.
16. Jurgens B, Schmitz-Drager BJ, Schulz WA (1996) Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res 56: 5698-5703.
17. Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, et al. (2000) DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet 89: 121-128.
18. Batanian JR, Cavalli LR, Aldosari NM, Ma E, Sotelo-Avila C, et. al. (2002) Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses. Mol Pathol 55: 389-393.
19. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, et al. (1995) Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosomes Cancer 14: 15-21.
20. Lim G, Karaskova J, Beheshti B, Vukovic B, Bayani J, et al. (2005) An integrated mBAND and submegahase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma. Genes Chromosomes Cancer 42: 392-403.
21. Lim G, Karaskova J, Vukovic B, Bayani J, Beheshti B, et. al. (2004) Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63. Cancer Genet Cytogenet 153: 158-164.
22. Squire JA, Pei J, Marrano P, Beheshti B, Bayani J, et al. (2003) High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chromosomes Cancer 38: 215-225.
23. Tarkkanen M, Elomaa I, Blomqvist C, Kivioja AH, Kellokumpu-Lehtinen P, et al. (1999) DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 84: 114-121.
24. Zielenska M, Bayani J, Pandita A, Toledo S, Marrano, P, et al. (2001) Comparative genomic hybridization analysis identifies gains of lp35 approximately p36 and chromosome 19 in osteosarcoma. Cancer Genet Cytogenet 130: 14-21.
25. Zielenska M, Marrano P, Thorner P, Pei J, Beheshti B, et al. (2004) High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue. Cytogenet Genome Res 107: 77-82.
26. Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karasko, J, et al. (2003) Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer 36: 7-16.
27. Ozaki T, Neumann T, Wai D, Schafer KL, van Valen F, et al. (2003) Chromosomal alterations in osteosarcoma cell lines revealed by comparative genomic hybridization and multicolor karyotyping. Cancer Genet Cytogenet 140: 145-152.
28. Sandberg AA, BridgejA (2003) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet 145: 1-30.
29. Selvarajah S, Yoshimoto M, Maire G, Paderova J, Bayani J, et al. (2007) Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization. Cancer Genet Cytogenet 179: 52-61.
30. Locklin RM, Oreffo RO, Triffitt JT (1998) Modulation of osteogenic differentiation in human skeletal cells in Vitro by 5-azacytidine. Cell Biol Int 22: 207-215.
31. Ryhanen S, Pirskanen A, Jaaskelainen T, Maenpaa PH (1997) State of methylation of the human osteocalcin gene in bone-derived and other types of cells. J Cell Biochem 66: 404-412.
32. Villagra. A, Gutierrez J, Paredes R, Sierra J, Puchi M, et al. (2002) Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J Cell Biochem 85: 112-122.
33. Ulaner GA, Vu TH, Li T, Hu JT, Yao XM, et al. (2003) Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Hum Mol Genet 12: 535-549.
34. Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, et al. (2002) Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 21: 4345-4349.
35. Al-Romaih K, Somers GR, Bayani J, Hughes S, Prasad M, et al. (2007) Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation. Cancer Cell Int 7: 14.
36. Al-Romaih K, Sadikovic B, Yoshimoto M, Yuzhuo W, Zielenska M, et al. (2008) Decitabine-induced demethylation of 5′ CpG island in GADD45A leads to apoptosis in osteosarcoma. cells. Neoplasia 10: 471-480.
37. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862.
38. Weber Al, Hellmann I, Stadler MB, Ramos L, Paabo S, et al. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39: 457-466.
39. Sadikovic P, Andrews J, Carter D, Robinson J, Rodenhiser DI (2008) Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells. J Biol Chem 283: 4051-4060.
40. DiNardo DN, Butcher DT, Robinson DP, Archer TK, Rodenhiser DI (2001) Functional analysis of CpG methylation in the BRCA1 promoter region. Oncogene 20: 5331-5340.
41. Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, et al. (1998) CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16: 1161-1169.
42. Mancini DN, Singh SM, Archer TK, Roderthiser DI (1999) Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene 18: 4108-4119.
43. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
44. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
45. Tsukamoto N, Morita K, Karasawa M, Omine M (1992) Methylation status of c-myc oncogene in leukemic cells: hypomethylation in acute leukemia derived from myelodysplastic syndromes. Exp Hematol 20: 1061-1064.
46. Kindich R, Florl AR, Kamradt J, Lehmann J, Muller M, et al. (2006) Relationship of N-KX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stage. Eur Urol 49: 169-175. discussion 175.
47. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, et al. (2008) Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leuk Res 32: 487-490.
48. Schulz WA, Elo JP, Florl AR, Pennanen S, Santourlidis S, et al. (2002) Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 35: 58-65.
49. Sharm YJ, Cheng C, Chiao CH, Chen DT, Li PH, et al. (2008) Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. Genome Res.
50. Wong N, Lam WC, Lai PB, Pang E, Lau WY, et al. (2001) Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol 159: 465-471.
51. Sugino Y, Misawa A, Inoue J, Kitagawa M, Hosoi H, et al. (2007) Epigenetic silencing ofprostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene 26: 7401-7413.
52. Zhang X, Shiu S, Cal A, Borevitz JO (2008) Global analysis of genetic, epigenetic and transcriptional polymorphisms in Arabidopsis thaliana using whole genome tiling arrays. PLoS Genet 4: e1000032.
53. Figueroa ME, Reimers M, Thompson RF, Ye K, Li Y, et al. (2008) An integrative genomic and epigenomic approach for the study or transcriptional regulation. PLoS ONE 3: e1882.
54. Bayani J, Zielenska M, Marrano P, Kwan Ng Y, Taylor MD, et al. (2000) Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. J Neurosurg 93: 437-148.
55. Maire G, Forus A, Foa C, Bjerkehagen B, Mainguene C, et al. (2003) 11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near CARP in 11q13.5. Genes Chromosomes Cancer 37: 389-395.